Functionalized fullerenes in photodynamic therapy

Journal of Biomedical Nanotechnology

Volumn 10, Issue 9, 2014, Pages 1918-1936

  Huang, Ying Ying ^a,b   Sharma, Sulbha K ^c   Yin, Rui ^a,b,d   Agrawal, Tanupriya ^a,b   Chiang, Long Y ^e   Hamblin, Michael R ^a,b,f  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c RAJA RAMANNA CENTRE FOR ADVANCED TECHNOLOGY   (India)

^d THIRD MILITARY MEDICAL UNIVERSITY   (China)

^e University of Massachusetts Lowell   (United States)

^f HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

Cancer; Cationic charge; Electron transfer; Fullerene; Infections; Photodynamic therapy; Reactive oxygen species; Singlet oxygen

Indexed keywords

MAMMALS; MEDICAL APPLICATIONS; MOLECULES; OXYGEN; PHOTODYNAMIC THERAPY; PHOTOSENSITIZERS;

CANCER; CATIONIC CHARGES; ELECTRON TRANSFER; INFECTIONS; REACTIVE OXYGEN SPECIES; SINGLET OXYGEN;

FULLERENES;

AMINOLEVULINIC ACID; DENDRIMER; FULLERENE DERIVATIVE; LIPOSOME; MACROGOL; PADOPORFIN; PHOTOFRIN; PHOTOSENSITIZING AGENT; ROSTAPORFIN; TALAPORFIN; TEMOPORFIN; TOBRAMYCIN; TOLONIUM CHLORIDE; VERTEPORFIN; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; FULLERENE C60;

ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; CANCER CELL; CHROMATOPHORE; COMPLEX FORMATION; DRUG CONJUGATION; DRUG DESIGN; DRUG SOLUBILITY; DRUG STRUCTURE; DRUG SYNTHESIS; IN VITRO STUDY; MICELLE; NANOENCAPSULATION; NONHUMAN; PHOTOCHEMISTRY; PHOTODYNAMIC THERAPY; PHOTOSENSITIZATION; PHOTOTOXICITY; REVIEW; WOUND INFECTION; ANIMAL; HUMAN; NEOPLASMS; PHOTOCHEMOTHERAPY;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; FULLERENES; HUMANS; NEOPLASMS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS;

EID: 84904871476     PISSN: 15507033     EISSN: 15507041     Source Type: Journal    
DOI: 10.1166/jbn.2014.1963     Document Type: Review

References (119)

1. B. W. Henderson and T. J. Dougherty, How does photodynamic therapy work? Photochem. Photobiol. 55, 145 (1992).
2. P. Agostinis, K. Berg, K. A. Cengel, T. H. Foster, A. W. Girotti, S. O. Gollnick, S. M. Hahn, M. R. Hamblin, A. Juzeniene, D. Kessel, M. Korbelik, J. Moan, P. Mroz, D. Nowis, J. Piette, B. C. Wilson, and J. Golab, Photodynamic therapy of cancer: An update. CA Cancer J. Clin. 61, 250 (2011).
3. R. W. Boyle and D. Dolphin, Structure and biodistribution relationships of photodynamic sensitizers. Photochem. Photobiol. 64, 469 (1996).
4. E. D. Sternberg, D. Dolphin, and C. Brückner, Porphyrin-based photosensitizers for use in photodynamic therapy. Tetrahedron 54, 4151 (1998).
5. K. Ravindra, R. K. Pandey, and G. Zheng, Porphyrins as photosensitizers in photodynamic therapy, The Porphyrin Handbook, edited by K. Kadish, R. Guilard, and K. M. Smiths, Elsevier, San Diego (2000), Vol. 6, pp. 157-161.
6. R. R. Allison, G. H. Downie, R. Cuenca, X.-H. Hu, C. J. Childs, and C. H. Sibata, Photosensitizers in clinical PDT. Photodiagnosis Photodyn. Ther. 1, 27 (2004).
7. R. A. Weersink, A. Bogaards, M. Gertner, S. R. Davidson, K. Zhang, G. Netchev, J. Trachtenberg, and B. C. Wilson, Techniques for delivery and monitoring of TOOKAD (WST09)-mediated photodynamic therapy of the prostate: Clinical experience and practicalities. J. Photochem. Photobiol. B: Biol. 79, 211 (2005).
8. C. Hopper, C. Niziol, and M. Sidhu, The cost-effectiveness of Foscan mediated photodynamic therapy (Foscan-PDT) compared with extensive palliative surgery and palliative chemotherapy for patients with advanced head and neck cancer in the UK. Oral Oncol. 40, 372 (2004).
9. B. Krammer and K. Plaetzer, ALA and its clinical impact, from bench to bedside. Photochem. Photobiol. Sci. 7, 283 (2008).
10. C. M. Allen, W. M. Sharman, and J. E. Van Lier, Current status of phthalocyanines in the photodynamic therapy of cancer. J. Porphyrins Phthalocyanines 5, 161 (2001).
11. T. G. St Denis and M. R. Hamblin, Synthesis, bioanalysis and biodistribution of photosensitizer conjugates for photodynamic therapy. Bioanalysis 5, 1099 (2013).
12. K. A. Leonard, M. I. Nelen, T. P. Simard, S. R. Davies, S. O. Gollnick, A. R. Oseroff, S. L. Gibson, R. Hilf, L. B. Chen, and M. R. Detty, Synthesis and evaluation of chalcogenopyrylium dyes as potential sensitizers for the photodynamic therapy of cancer. J. Med. Chem. 42, 3953 (1999).
13. F. Harris, L. K. Chatfield, and D. A. Phoenix, Phenothiazinium based photosensitisers-photodynamic agents with a multiplicity of cellular targets and clinical applications. Curr. Drug Targets 6, 615 (2005).
14. C. W. Lin, J. R. Shulok, Y. K. Wong, C. F. Schanbacher, L. Cincotta, and J. W. Foley, Photosensitization, uptake, and retention of phenoxazine Nile blue derivatives in human bladder carcinoma cells. Cancer Res. 51, 1109 (1991).
15. M. Olivo and W. Chin, Perylenequinones in photodynamic therapy: Cellular versus vascular response. J. Environ. Pathol. Toxicol. Oncol. 25, 223 (2006).
16. A. Kamkaew, S. H. Lim, H. B. Lee, L. V. Kiew, L. Y. Chung, and K. Burgess, BODIPY dyes in photodynamic therapy. Chem. Soc. Rev. 42, 77 (2013).
17. R. R. Avirah, D. T. Jayaram, N. Adarsh, and D. Ramaiah, Squaraine dyes in PDT: From basic design to in vivo demonstration. Org. Biomol. Chem. 10, 911 (2012).
18. G. J. Kavarnos and N. J. Turro, Photosensitization by reversible electron transfer: Theories, experimental evidence, and examples. Chem. Rev. 86, 401 (1986).
19. G. Accorsi and N. Armaroli, Taking advantage of the electronic excited states of [60]-fullerenes. J. Phys. Chem. C 114, 1385 (2010).
20. P. Mroz, A. Pawlak, M. Satti, H. Lee, T. Wharton, H. Gali, T. Sarna, and M. R. Hamblin, Functionalized fullerenes mediate photodynamic killing of cancer cells: Type I versus Type II photochemical mechanism. Free Radic. Biol. Med. 43, 711 (2007).
21. M. Wang, V. Nalla, S. Jeon, V. Mamidala, W. Ji, L.-S. Tan, T. Cooper, and L. Y. Chiang, Large femtosecond two-photon absorption cross sections of fullerosome vesicle nanostructures derived from a highly photoresponsive amphiphilic C60-light-harvesting fluorene dyad. J. Phys. Chem. C 115, 18552 (2011).
22. L. Culotta and D. E. Koshland, Jr, Buckyballs: Wide open playing field for chemists. Science 254, 1706 (1991).
23. J. Meng, D. L. Wang, P. C. Wang, L. Jia, C. Chen, and X. J. Liang, Biomedical activities of endohedral metallofullerene optimized for nanopharmaceutics. J. Nanosci. Nanotechnol. 10, 8610 (2010).
24. J. A. Brant, J. Labille, C. O. Robichaud, and M. Wiesner, Fullerol cluster formation in aqueous solutions: Implications for environmental release. J. Colloid Interface Sci. 314, 281 (2007).
25. G. Angelini, P. De Maria, A. Fontana, M. Pierini, M. Maggini, F. Gasparrini, and G. Zappia, Study of the aggregation properties of a novel amphiphilic C60 fullerene derivative. Langmuir 17, 6404 (2001).
26. J. Baffreau, S. Leroy-Lhez, N. Vân Anh, R. M. Williams, and P. Hudhomme, Fullerene C60-Perylene-3, 4:9, 10-bis (dicarboximide) light-harvesting dyads: Spacer-length and bay-substituent effects on intramolecular singlet and triplet energy transfer. Chem. Eur. J. 14, 4974 (2008).
27. V. V. Tuchin, R. K. Wang, and A. T. Yeh, Optical clearing of tissues and cells. J. Biomed. Opt. 13, 021101 (2008).
28. J. Hirshburg, B. Choi, J. S. Nelson, and A. T. Yeh, Correlation between collagen solubility and skin optical clearing using sugars. Lasers Surg. Med. 39, 140 (2007).
29. J. Jiang, M. Boese, P. Turner, and R. K. Wang, Penetration kinetics of dimethyl sulphoxide and glycerol in dynamic optical clearing of porcine skin tissue in vitro studied by Fourier transform infrared spectroscopic imaging. J. Biomed. Opt. 13, 021105 (2008).
30. A. Kogan and N. Garti, Microemulsions as transdermal drug delivery vehicles. Adv. Colloid Interface Sci. 123-126, 369 (2006).
31. J. D. Bhawalkar, N. D. Kumar, C. F. Zhao, and P. N. Prasad, Two-photon photodynamic therapy. J. Clin. Laser Med. Surg. 15, 201 (1997).
32. A. Karotki, M. Khurana, J. R. Lepock, and B. C. Wilson, Simultaneous two-photon excitation of photofrin in relation to photodynamic therapy. Photochem. Photobiol. 82, 443 (2006).
33. K. S. Samkoe, A. A. Clancy, A. Karotki, B. C. Wilson, and D. T. Cramb, Complete blood vessel occlusion in the chick chorioallantoic membrane using two-photon excitation photodynamic therapy: Implications for treatment of wet age-related macular degeneration. J. Biomed. Opt. 12, 034025 (2007).
34. K. S. Samkoe and D. T. Cramb, Application of an ex ovo chicken chorioallantoic membrane model for two-photon excitation photodynamic therapy of age-related macular degeneration. J. Biomed. Opt. 8, 410 (2003).
35. G. Oberdorster, Safety assessment for nanotechnology and nanomedicine: Concepts of nanotoxicology. J. Intern. Med. 267, 89 (2010).
36. J. W. Arbogast, A. P. Darmanyan, C. S. Foote, F. N. Diederich, R. Whetten, Y. Rubin, M. M. Alvarez, and S. J. Anz, Photophysical properties of sixty atom carbon molecule (C60). J. Phys. Chem. A 95, 11 (1991).
37. R. Haddon, L. E. Brus, and K. Raghavachari, Electronic structure and bonding in icosahedral C60. Chem. Phys. Lett. 125, 459 (1986).
38. W. Wu, J. Zhao, J. Sun, and S. Guo, Light-harvesting fullerene dyads as organic triplet photosensitizers for triplet-triplet annihilation upconversions. J. Org. Chem. 77, 5305 (2012).
39. Y. Yamakoshi, N. Umezawa, A. Ryu, K. Arakane, N. Miyata, Y. Goda, T. Masumizu, and T. Nagano, Active oxygen species generated from photoexcited fullerene (C60) as potential medicines: O2-&z.ast; versus 1O2. J. Am. Chem. Soc. 125, 12803 (2003).
40. Q. Xie, E. Perez-Cordero, and L. Echegoyen, Electrochemical detection of C606-and C706-: Enhanced stability of fullerides in solution. J. Am. Chem. Soc. 114, 3978 (1992).
41. D. M. Guldi and M. Prato, Excited-state properties of C(60) fullerene derivatives. Acc. Chem. Res. 33, 695 (2000).
42. K. Ohkubo, H. Kitaguchi, and S. Fukuzumi, Activation of electron-transfer reduction of oxygen by hydrogen bond formation of superoxide anion with ammonium ion. J. Phys. Chem. A 110, 11613 (2006).
43. G. V. Andrievsky, V. I. Bruskov, A. A. Tykhomyrov, and S. V. Gudkov, Peculiarities of the antioxidant and radioprotective effects of hydrated C60 fullerene nanostuctures in vitro and in vivo. Free Radic. Biol. Med. 47, 786 (2009).
44. M. V. Avdeev, A. A. Khokhryakov, T. V. Tropin, G. V. Andrievsky, V. K. Klochkov, L. I. Derevyanchenko, L. Rosta, V. M. Garamus, V. B. Priezzhev, M. V. Korobov, and V. L. Aksenov, Structural features of molecular-colloidal solutions of C60 fullerenes in water by small-angle neutron scattering. Langmuir 20, 4363 (2004).
45. B. de La Vaissière, J. P. Sandall, P. W. Fowler, P. de Oliveira, and R. V. Bensasson, Regioselectivity in radical reactions of C60 derivatives. J. Chem. Soc. Perkin 2, 821 (2001).
46. N. Gharbi, M. Pressac, M. Hadchouel, H. Szwarc, S. R. Wilson, and F. Moussa, [60]fullerene is a powerful antioxidant in vivo with no acute or subacute toxicity. Nano Lett. 5, 2578 (2005).
47. S. Kato, H. Aoshima, Y. Saitoh, and N. Miwa, Fullerene-C60/liposome complex: Defensive effects against UVA-induced damages in skin structure, nucleus and collagen type I/IV fibrils, and the permeability into human skin tissue. J. Photochem. Photobiol. B 98, 99 (2010).
48. Y. Doi, A. Ikeda, M. Akiyama, M. Nagano, T. Shigematsu, T. Ogawa, T. Takeya, and T. Nagasaki, Intracellular uptake and photodynamic activity of water-soluble [60]- and [70]fullerenes incorporated in liposomes. Chemistry 14, 8892 (2008).
49. A. Yan, A. Von Dem Bussche, A. B. Kane, and R. H. Hurt, Tocopheryl polyethylene glycol succinate as a safe, antioxidant surfactant for processing carbon nanotubes and fullerenes. Carbon N Y 45, 2463 (2007).
50. M. Akiyama, A. Ikeda, T. Shintani, Y. Doi, J. Kikuchi, T. Ogawa, K. Yogo, T. Takeya, and N. Yamamoto, Solubilisation of [60]fullerenes using block copolymers and evaluation of their photodynamic activities. Org. Biomol. Chem. 6, 1015 (2008).
51. C. Kojima, Y. Toi, A. Harada, and K. Kono, Aqueous solubilization of fullerenes using poly(amidoamine) dendrimers bearing cyclodextrin and poly(ethylene glycol). Bioconjug. Chem. 19, 2280 (2008).
52. B. Pan, D. Cui, P. Xu, C. Ozkan, G. Feng, M. Ozkan, T. Huang, B. Chu, Q. Li, R. He, and G. Hu, Synthesis and characterization of polyamidoamine dendrimer-coated multi-walled carbon nanotubes and their application in gene delivery systems. Nanotechnology 20, 125101 (2009).
53. J. B. Hooper, D. Bedrov, and G. D. Smith, Supramolecular self-organization in PEO-modified C60 fullerene/water solutions: Influence of polymer molecular weight and nanoparticle concentration. Langmuir 24, 4550 (2008).
54. N. Nitta, A. Seko, A. Sonoda, S. Ohta, T. Tanaka, M. Takahashi, K. Murata, S. Takemura, T. Sakamoto, and Y. Tabata, Is the use of fullerene in photodynamic therapy effective for atherosclerosis? Cardiovasc. Intervent. Radiol. 31, 359 (2008).
55. J. Liu, S. Ohta, A. Sonoda, M. Yamada, M. Yamamoto, N. Nitta, K. Murata, and Y. Tabata, Preparation of PEG-conjugated fullerene containing Gd3+ ions for photodynamic therapy. J. Control Release 117, 104 (2007).
56. Y. Tabata, Y. Murakami, and Y. Ikada, Photodynamic effect of polyethylene glycol-modified fullerene on tumor. Jpn. J. Cancer Res. 88, 1108 (1997).
57. V. Bali, M. Ali, and J. Ali, Novel nanoemulsion for minimizing variations in bioavailability of ezetimibe. J. Drug Target. 18, 506 (2010).
58. A. Amani, P. York, H. Chrystyn, and B. J. Clark, Factors affecting the stability of nanoemulsions - use of artificial neural networks. Pharm. Res. 27, 37 (2010).
59. T. Bansal, G. Mustafa, Z. I. Khan, F. J. Ahmad, R. K. Khar, and S. Talegaonkar, Solid self-nanoemulsifying delivery systems as a platform technology for formulation of poorly soluble drugs. Crit. Rev. Ther. Drug Carrier Syst. 25, 63 (2008).
60. F. Shakeel and M. S. Faisal, Nanoemulsion: A promising tool for solubility and dissolution enhancement of celecoxib. Pharm. Dev. Technol. 15, 53 (2010).
61. S. Filippone, F. Heimann, and A. Rassat, A highly water-soluble 2:1 beta-cyclodextrin-fullerene conjugate. Chem. Commun. (Camb.), 1508 (2002).
62. B. Zhao, Y. Y. He, P. J. Bilski, and C. F. Chignell, Pristine (C60) and hydroxylated [C60(OH)24] fullerene phototoxicity towards HaCaT keratinocytes: Type I versus type II mechanisms. Chem. Res. Toxicol. 21, 1056 (2008).
63. E. Nakamura and H. Isobe, Functionalized fullerenes in water. The first 10 years of their chemistry, biology, and nanoscience. Acc. Chem. Res. 36, 807 (2003).
64. M. A. Yurovskaya and I. V. Trushkov, Cycloaddition to buckmin-sterfullerene C60: Advancements and future prospects. Russ. Chem. Bull. 51, 367 (2002).
65. M. Maggini, G. Scorrano, and M. Prato, Addition of azomethine ylides to C60: Synthesis, characterization, and functionalization of fullerene pyrrolidines. J. Am. Chem. Soc. 115, 9798 (1993).
66. M. Wang, L. Huang, S. K. Sharma, S. Jeon, S. Thota, F. F. Sperandio, S. Nayka, J. Chang, M. R. Hamblin, and L. Y. Chiang, Synthesis and photodynamic effect of new highly photostable decacationically armed [60]- and [70]fullerene decaiodide monoadducts to target pathogenic bacteria and cancer cells. J. Med. Chem. 55, 4274 (2012).
67. F. F. Sperandio, S. K. Sharma, M. Wang, S. Jeon, Y. Y. Huang, T. Dai, S. Nayka, S. C. de Sousa, L. Y. Chiang, and M. R. Hamblin, Photoinduced electron-transfer mechanisms for radical-enhanced photodynamic therapy mediated by water-soluble decacationic C70 and C84O2 Fullerene Derivatives. Nanomedicine 9, 570 (2013).
68. M. Brettreich, S. Burghardt, C. Bottcher, T. Bayerl, S. Bayerl, and A. Hirsch, Globular amphiphiles: Membrane-forming hexaadducts of C(60). Angew. Chem. Int. Ed. Engl. 39, 1845 (2000).
69. G. P. Tegos, T. N. Demidova, D. Arcila-Lopez, H. Lee, T. Wharton, H. Gali, and M. R. Hamblin, Cationic fullerenes are effective and selective antimicrobial photosensitizers. Chem. Biol. 12, 1127 (2005).
70. M. Wang, S. Maragani, L. Huang, S. Jeon, T. Canteenwala, M. R. Hamblin, and L. Y. Chiang, Synthesis of decacationic [60]fullerene decaiodides giving photoinduced production of superoxide radicals and effective PDT-mediation on antimicrobial photoinactivation. Eur. J. Med. Chem. 63, 170 (2013).
71. S. Thota, M. Wang, S. Jeon, S. Maragani, M. R. Hamblin, and L. Y. Chiang, Synthesis and characterization of positively charged pentacationic [60]fullerene monoadducts for antimicrobial photodynamic inactivation. Molecules 17, 5225 (2012).
72. C. Constantin, M. Neagu, R. M. Ion, M. Gherghiceanu, and C. Stavaru, Fullerene-porphyrin nanostructures in photodynamic therapy. Nanomedicine (Lond.) 5, 307 (2010).
73. L. Y. Chiang, P. A. Padmawar, J. E. Rogers-Haley, G. So, T. Canteenwala, S. Thota, L. S. Tan, K. Pritzker, Y. Y. Huang, S. K. Sharma, D. B. Kurup, M. R. Hamblin, B. Wilson, and A. Urbas, Synthesis and characterization of highly photoresponsive fullerenyl dyads with a close chromophore antenna-C(60) contact and effective photodynamic potential. J. Mater. Chem. 20, 5280 (2010).
74. M. E. El-Khouly, P. Padmawar, Y. Araki, S. Verma, L. Y. Chiang, and O. Ito, Photoinduced processes in a tricomponent molecule consisting of diphenylaminofluorene-dicyanoethylenemethano[60]fullerene. J. Phys. Chem. A 110, 884 (2006).
75. G. P. Tegos, T. N. Demidova, D. Arcila-Lopez, H. Lee, T. Wharton, H. Gali, and M. R. Hamblin, Cationic fullerenes are effective and selective antimicrobial photosensitizers. Chem. Biol. 12, 1127 (2005).
76. F. Diederich and M. Gómez-López, Supramolecular fullerene chemistry. Chem. Soc. Rev. 28, 263 (1999).
77. K. M. Kadish and R. S. Ruoff, (eds.), Fullerenes: Chemistry, Physics, and Technology, John Wiley & Sons Inc., New York (2000).
78. Z. Hu, W. Guan, W. Wang, L. Huang, H. Xing, and Z. Zhu, Protective effect of a novel cystine C(60) derivative on hydrogen peroxide-induced apoptosis in rat pheochromocytoma PC12 cells. Chem. Biol. Interact. 167, 135 (2007).
79. C. Bingel, ChemInform abstract: Cyclopropylation of fullerenes. ChemInform 25, 1957 (1994).
80. M. Maggini, G. Scorrano, and M. Prato, Addition of azomethine ylides to C60 - synthesis, characterization, and functionalization of fullerenes pyrrolidines. J. Am. Chem. Soc. 115, 9798 (1993).
81. Z. Lu, T. Dai, L. Huang, D. B. Kurup, G. P. Tegos, A. Jahnke, T. Wharton, and M. R. Hamblin, Photodynamic therapy with a cationic functionalized fullerene rescues mice from fatal wound infections. Nanomedicine (Lond.) 5, 1525 (2010).
82. K. Mizuno, T. Zhiyentayev, L. Huang, S. Khalil, F. Nasim, G. P. Tegos, H. Gali, A. Jahnke, T. Wharton, and M. R. Hamblin, Antimicrobial photodynamic therapy with functionalized fullerenes: Quantitative structure-activity relationships. J. Nanomed. Nanotechnol. 2, 1 (2011).
83. M. Wang, L. Huang, S. K. Sharma, S. Jeon, S. Thota, F. F. Sperandio, S. N. Nayka, J. Chang, M. R. Hamblin, and L. Y. Chiang, Synthesis and photodynamic effect of new highly photostable decacationically armed [60]-and [70] fullerene decaiodide monoadducts to target pathogenic bacteria and cancer cells. J. Med. Chem. 55, 4274 (2012).
84. J. B. Bhonsle, Y. Chi, J. P. Huang, J. Shiea, B. J. Chen, and L. Y. Chiang, Novel water-soluble hexa(sulfobutyl)fullerenes as potent free radical scavengers. Chem. Lett. 27, 465 (1998).
85. C. Yu, T. Canteenwala, M. E. El-Khouly, Y. Araki, K. Pritzker, O. Ito, B. C. Wilson, and L. Y. Chiang, Efficiency of singlet oxygen production from self-assembled nanospheres of molecular micelle-like photosensitizers FC4S. J. Mater. Chem. 15, 857 (2005).
86. U. S. Jeng, T. L. Lin, C. S. Tsao, L. C. H., T. Canteenwala, L. Y. Wang, L. Y. Chiang, and C. C. Han, Study of aggregates of fullerene-based ionomers in aqueous solutions using small angle neutron and X-ray scattering. J. Phys. Chem. B 103, 1059 (1999).
87. D. M. Guldi and K. D. Asmus, Photophysical properties of mono- and multiply-functionalized fullerene derivatives. J. Phys. Chem. B 101, 1472 (1997).
88. R. V. Bensasson, M. N. Berberan-Santos, M. Bretreich, J. Frederiksen, H. Göttinger, A. Hirsch, E. J. Land, S. Leach, D. J. McGarvey, H. Schönberger, and C. Schröder, Triplet state properties of malonic acid C60 derivatives C60 [C(COOR)2]n; R=H, Et; n = 1-6. Phys. Chem. Chem. Phys. 3, 4679 (2001).
89. S. Foley, C. Crowley, M. Smaihi, C. Bonfils, B. F. Erlanger, P. Seta, and C. Larroque, Cellular localisation of a water-soluble fullerene derivative. Biochem. Biophys. Res. Commun. 294, 116 (2002).
90. A. E. Porter, M. Gass, K. Muller, J. N. Skepper, P. Midgley, and M. Welland, Visualizing the uptake of C60 to the cytoplasm and nucleus of human monocyte-derived macrophage cells using energy-filtered transmission electron microscopy and electron tomography. Environ. Sci. Technol. 41, 3012 (2007).
91. H. Tokuyama, S. Yamago, E. Nakamura, T. Shiraki, and Y. Sugiura, Photoinduced biochemical activity of fullerene carboxylic acid. J. Am. Chem. Soc. 115, 7918 (1993).
92. A. P. Burlaka, Y. P. Sidorik, S. V. Prylutska, O. P. Matyshevska, O. A. Golub, Y. I. Prylutskyy, and P. Scharff, Catalytic system of the reactive oxygen species on the C60 fullerene basis. Exp. Oncol. 26, 326 (2004).
93. F. Rancan, S. Rosan, F. Boehm, A. Cantrell, M. Brellreich, H. Schoenberger, A. Hirsch, and F. Moussa, Cytotoxicity and photocytotoxicity of a dendritic C(60) mono-adduct and a malonic acid C(60) tris-adduct on Jurkat cells. J. Photochem. Photobiol. B 67, 157 (2002).
94. F. Rancan, M. Helmreich, A. Molich, N. Jux, A. Hirsch, B. Roder, C. Witt, and F. Bohm, Fullerene-pyropheophorbide a complexes as sensitizer for photodynamic therapy: Uptake and photo-induced cytotoxicity on Jurkat cells. J. Photochem. Photobiol. B 80, 1 (2005).
95. R. Li, D. J. Bounds, D. Granville, S. H. Ip, H. Jiang, P. Margaron, and D. W. Hunt, Rapid induction of apoptosis in human keratinocytes with the photosensitizer QLT0074 via a direct mitochondrial action. Apoptosis 8, 269 (2003).
96. S. Gupta, N. Ahmad, and H. Mukhtar, Involvement of nitric oxide during phthalocyanine (Pc4) photodynamic therapy-mediated apoptosis. Cancer Res. 58, 1785 (1998).
97. M. Elisa Milanesio, M. G. Alvarez, V. Rivarola, J. J. Silber, and E. N. Durantini, Porphyrin-fullerene C60 dyads with high ability to form photoinduced charge-separated state as novel sensitizers for photodynamic therapy. Photochem. Photobiol. 81, 891 (2005).
98. M. G. Alvarez, C. Prucca, M. E. Milanesio, E. N. Durantini, and V. Rivarola, Photodynamic activity of a new sensitizer derived from porphyrin-C60 dyad and its biological consequences in a human carcinoma cell line. Int. J. Biochem. Cell Biol. 38, 2092 (2006).
99. M. Elisa Milanesio, M. Gabriela Alvarez, and E. N. Durantini, Methoxyphenyl porphyrin derivatives as phototherapeutic agents. Curr. Bioact. Compd. 6, 97 (2010).
100. P. Mroz, G. P. Tegos, H. Gali, T. Wharton, T. Sarna, and M. R. Hamblin, Photodynamic therapy with fullerenes. Photochem. Photobiol. Sci. 6, 1139 (2007).
101. C. Yu, T. Canteenwala, H. H. Chen, U.-S. Jeng, T.-L. Lin, and L. Y. Chiang, Free radical scavenging and photodynamic functions of micelle-like hydrophilic hexa (sulfobutyl) fullerene (FC4S), Perspectives of Fullerene Nanotechnology, edited by E. Ōsawas, Springer, Netherlands (2002), pp. 165-183.
102. P. Mroz, Y. Xia, D. Asanuma, A. Konopko, T. Zhiyentayev, Y. Y. Huang, S. K. Sharma, T. Dai, U. J. Khan, T. Wharton, and M. R. Hamblin, Intraperitoneal photodynamic therapy mediated by a fullerene in a mouse model of abdominal dissemination of colon adenocarcinoma. Nanomedicine 7, 965 (2011).
103. E. Otake, S. Sakuma, K. Torii, A. Maeda, H. Ohi, S. Yano, and A. Morita, Effect and mechanism of a new photodynamic therapy with glycoconjugated fullerene. Photochem. Photobiol. 86, 1356 (2010).
104. T. Maisch, A new strategy to destroy antibiotic resistant microorganisms: Antimicrobial photodynamic treatment. Mini Rev. Med. Chem. 9, 974 (2009).
105. D. A. Talan, MRSA: Deadly super bug or just another staph? Ann. Emerg. Med. 51, 299 (2008).
106. M. R. Hamblin and T. Hasan, Photodynamic therapy: A new antimicrobial approach to infectious disease? Photochem. Photobiol. Sci. 3, 436 (2004).
107. R. E. Hancock and A. Bell, Antibiotic uptake into gram-negative bacteria. Eur. J. Clin. Microbiol. Infect. Dis. 7, 713 (1988).
108. J. P. Martin and N. Logsdon, The role of oxygen radicals in dye-mediated photodynamic effects in Escherichia coli B. J. Biol. Chem. 262, 7213 (1987).
109. L. K. Duncan, J. R. Jinschek, and P. J. Vikesland, C60 colloid formation in aqueous systems: Effects of preparation method on size, structure, and surface charge. Environ. Sci. Technol. 42, 173 (2008).
110. T. Mashino, N. Usui, K. Okuda, T. Hirota, and M. Mochizuki, Respiratory chain inhibition by fullerene derivatives: Hydrogen peroxide production caused by fullerene derivatives and a respiratory chain system. Bioorg. Med. Chem. 11, 1433 (2003).
111. T. Mashino, K. Okuda, T. Hirota, M. Hirobe, T. Nagano, and M. Mochizuki, Inhibition of E. coli growth by fullerene derivatives and inhibition mechanism. Bioorg. Med. Chem. Lett. 9, 2959 (1999).
112. M. B. Spesia, M. E. Milanesio, and E. N. Durantini, Synthesis, properties and photodynamic inactivation of Escherichia coli by novel cationic fullerene C60 derivatives. Eur. J. Med. Chem. 43, 853 (2008).
113. T. Dai, Y. Y. Huang, S. K. Sharma, J. T. Hashmi, D. B. Kurup, and M. R. Hamblin, Topical antimicrobials for burn wound infections. Recent. Pat. Antiinfect. Drug Discov. 5, 124 (2010).
114. T. A. Dahl, W. R. Midden, and P. E. Hartman, Comparison of killing of gram-negative and gram-positive bacteria by pure singlet oxygen. J. Bacteriol. 171, 2188-2194 (1989).
115. G. Valduga, G. Bertoloni, E. Reddi, and G. Jori, Effect of extracellularly generated singlet oxygen on gram-positive and gram-negative bacteria. J. Photochem. Photobiol. B 21, 81 (1993).
116. R. N. Ollstein and C. McDonald, Topical and systemic antimicrobial agents in burns. Ann. Plast. Surg. 5, 386 (1980).
117. J. R. Saffle, Closure of the excised burn wound: Temporary skin substitutes. Clin. Plast. Surg. 36, 627 (2009).
118. T. Dai, Y. Y. Huang, S. K. Sharma, J. T. Hashmi, D. B. Kurup, and M. R. Hamblin, Topical antimicrobials for burn wound infections. Recent Pat. Antiinfect. Drug Discov. 5, 124 (2010).
119. L. Huang, M. Wang, T. Dai, F. F. Sperandio, Y. Y. Huang, Y. Xuan, L. Y. Chiang, and M. R. Hamblin, Antimicrobial photodynamic therapy with decacationic monoadducts and bisadducts of [70]fullerene: In vitro and in vivo studies. Nanomedicine (Lond.) 9, 253 (2013).